Liver Resection for Type IV Perihilar Cholangiocarcinoma: Left or Right Trisectionectomy?

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2022 Jun 10

PMID 35681768

Authors

Heithem Jeddou

Stylianos Tzedakis

Francesco Orlando

Antoine Robert

Eric Meneyrol

Damien Bergeat

Fabien Robin

Laurent Sulpice

Karim Boudjema

Affiliations

Soon will be listed here.

Abstract

How the side of an extended liver resection impacts the postoperative prognosis of advanced perihilar cholangiocarcinoma (PHC) is still controversial. We compared the outcomes of right (RTS) and left trisectionectomies (LTS) in Bismuth-Corlette (BC) type IV PHC resection. All patients undergoing RTS or LTS for BC type IV PHC in a single tertiary center between January 2012 and December 2019 were compared retrospectively. The endpoints were perioperative outcomes, long-term overall (OS), and disease-free survival (DFS). Among 67 hepatic resections for BC type IV PHC, 25 (37.3%) were LTS and 42 (63.7%) were RTS. Portal vein and artery resection rates were 40% and 52.4% (p = 0.29), and 24% and 0% (p < 0.001) in the LTS and RTS groups, respectively. The severe complication (Clavien−Dindo > IIIa) rate was comparable (36% vs. 21.5%, p = 0.357) while the postoperative liver failure (POLF) rate was lower in the LTS group (16% vs. 38%, p = 0.048). The R0 resection rate was similar between groups (81% vs. 92%; p = 0.154). The five-year OS rate was higher in the LTS group (66% vs. 30%, p = 0.009) while DFS was comparable (43% vs. 18%, p = 0.11). Based on multivariable analysis, the side of the trisectionectomy was an independent predictor of OS. Compared with RTS, LTS is associated with lower POLF and higher overall survival despite more frequent arterial reconstructions in type IV PHC. Although technically more demanding, LTS may be preferred in the treatment of advanced PHC.

References

Higuchi R, Yazawa T, Uemura S, Izumo W, Ota T, Kiyohara K . Surgical Outcomes for Perihilar Cholangiocarcinoma with Vascular Invasion. J Gastrointest Surg. 2018; 23(7):1443-1453. DOI: 10.1007/s11605-018-3948-x. View

Ebata T, Kamiya J, Nishio H, Nagasaka T, Nimura Y, Nagino M . The concept of perihilar cholangiocarcinoma is valid. Br J Surg. 2009; 96(8):926-34. DOI: 10.1002/bjs.6655. View

Strasberg S . Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg. 2005; 12(5):351-5. DOI: 10.1007/s00534-005-0999-7. View

Primrose J, Fox R, Palmer D, Malik H, Prasad R, Mirza D . Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019; 20(5):663-673. DOI: 10.1016/S1470-2045(18)30915-X. View

Carneiro C, Brito J, Bilreiro C, Barros M, Bahia C, Santiago I . All about portal vein: a pictorial display to anatomy, variants and physiopathology. Insights Imaging. 2019; 10(1):38. PMC: 6428891. DOI: 10.1186/s13244-019-0716-8. View

Jo H, Kim D, Yu Y, Kang W, Yoon K . Right-side versus left-side hepatectomy for the treatment of hilar cholangiocarcinoma: a comparative study. World J Surg Oncol. 2020; 18(1):3. PMC: 6942359. DOI: 10.1186/s12957-019-1779-1. View

Vibert E, Pittau G, Gelli M, Sa Cunha A, Jamot L, Faivre J . Actual incidence and long-term consequences of posthepatectomy liver failure after hepatectomy for colorectal liver metastases. Surgery. 2014; 155(1):94-105. DOI: 10.1016/j.surg.2013.05.039. View

Angelico R, Sensi B, Parente A, Siragusa L, Gazia C, Tisone G . Vascular Involvements in Cholangiocarcinoma: Tips and Tricks. Cancers (Basel). 2021; 13(15). PMC: 8345051. DOI: 10.3390/cancers13153735. View

Komaya K, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T . Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A propensity score matching analysis of resectable perihilar cholangiocarcinoma. Surgery. 2016; 161(2):394-404. DOI: 10.1016/j.surg.2016.08.008. View

10.

Edeline J, Benabdelghani M, Bertaut A, Watelet J, Hammel P, Joly J . Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study. J Clin Oncol. 2019; 37(8):658-667. DOI: 10.1200/JCO.18.00050. View

11.

Lee S, Song G, Hwang S, Ha T, Moon D, Jung D . Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Sci. 2009; 17(4):476-89. DOI: 10.1007/s00534-009-0204-5. View

12.

Nagino M, Nimura Y, Nishio H, Ebata T, Igami T, Matsushita M . Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg. 2010; 252(1):115-23. DOI: 10.1097/SLA.0b013e3181e463a7. View

13.

Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S . Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990; 14(4):535-43; discussion 544. DOI: 10.1007/BF01658686. View

14.

Nagino M, DeMatteo R, Lang H, Cherqui D, Malago M, Kawakatsu S . Proposal of a New Comprehensive Notation for Hepatectomy: The "New World" Terminology. Ann Surg. 2021; 274(1):1-3. DOI: 10.1097/SLA.0000000000004808. View

15.

Ratti F, Cipriani F, Piozzi G, Catena M, Paganelli M, Aldrighetti L . Comparative Analysis of Left- Versus Right-sided Resection in Klatskin Tumor Surgery: can Lesion Side be Considered a Prognostic Factor?. J Gastrointest Surg. 2015; 19(7):1324-33. DOI: 10.1007/s11605-015-2840-1. View

16.

Ebata T, Mizuno T, Yokoyama Y, Igami T, Sugawara G, Nagino M . Surgical resection for Bismuth type IV perihilar cholangiocarcinoma. Br J Surg. 2017; 105(7):829-838. DOI: 10.1002/bjs.10556. View

17.

Blechacz B . Cholangiocarcinoma: Current Knowledge and New Developments. Gut Liver. 2016; 11(1):13-26. PMC: 5221857. DOI: 10.5009/gnl15568. View

18.

Bismuth H, Corlette M . Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975; 140(2):170-8. View

19.

Grandadam S, Compagnon P, Arnaud A, Olivie D, Malledant Y, Meunier B . Role of preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma type III. Ann Surg Oncol. 2010; 17(12):3155-61. DOI: 10.1245/s10434-010-1168-z. View

20.

Mizuno T, Ebata T, Nagino M . Advanced hilar cholangiocarcinoma: An aggressive surgical approach for the treatment of advanced hilar cholangiocarcinoma: Perioperative management, extended procedures, and multidisciplinary approaches. Surg Oncol. 2019; 33:201-206. DOI: 10.1016/j.suronc.2019.07.002. View